Capital Analysts LLC
IBBQ icon

Capital Analysts LLC’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Capital Analysts LLC’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-500
Closed -$9K – 1108
2022
Q3 		$9K Sell
500
-700
-58% -$13.9K ﹤0.01% 818
2022
Q2 		$23K Buy
+1,200
New +$22.9K ﹤0.01% 683

Other funds holding IBBQ

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.8B AUM 57.69% 1-Year Est. Return
Banco BTG Pactual
Banco BTG Pactual Rio De Janeiro, Brazil $1.19B AUM 33.04% 1-Year Est. Return
Raymond James Financial Services Advisors
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Clarius Group LLC
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Lake Street Advisors Group
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
Partners Capital Investment Group
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
Capital Investment Advisory Services
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Capital Analysts LLC's IBBQ Position: Q4 2022 in Review

Capital Analysts LLC sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q4 2022, closing a stake of 500 shares — an estimated $9K sold.

Capital Analysts LLC first reported a position in IBBQ in Q2 2022 and held it in 2 quarters. The position peaked at $23K in Q2 2022. 14 funds tracked by Wall St. Rank hold IBBQ as of Q4 2022.

  • Capital Analysts LLC reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q4 2022 after selling out during the quarter.
  • Capital Analysts LLC sold 500 Invesco NASDAQ Biotechnology ETF shares in Q4 2022, an estimated $9K.
  • Capital Analysts LLC first reported a position in Invesco NASDAQ Biotechnology ETF in Q2 2022 and held it in 2 quarters.
  • Capital Analysts LLC's Invesco NASDAQ Biotechnology ETF position peaked at $23K in Q2 2022.
  • 14 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q4 2022.

Based on Capital Analysts LLC's 13F filing for Q4 2022, filed 8 Feb 2023.